Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The roles of histone deacetylases in kidney development and disease
Hongbing Liu
Clinical and Experimental Nephrology (2021) Vol. 25, Iss. 3, pp. 215-223
Open Access | Times Cited: 23

Showing 23 citing articles:

Osr2 functions as a biomechanical checkpoint to aggravate CD8+ T cell exhaustion in tumor
Jinjia Zhang, Junhong Li, Yongqiang Hou, et al.
Cell (2024) Vol. 187, Iss. 13, pp. 3409-3426.e24
Closed Access | Times Cited: 41
FoxO3 and oxidative stress: a multifaceted role in cellular adaptation
Victoria Simões Bernardo, Flaviene Felix Torres, Danilo Grünig Humberto da Silva
Journal of Molecular Medicine (2023) Vol. 101, Iss. 1-2, pp. 83-99
Closed Access | Times Cited: 37
METTL3-Mediated N6-Methyladenosine mRNA Modification and cGAS-STING Pathway Activity in Kidney Fibrosis
Yu-Cheng Tsai, Tsung‐Han Hsieh, Yuan‐Ru Liao, et al.
Journal of the American Society of Nephrology (2024) Vol. 35, Iss. 10, pp. 1312-1329
Closed Access | Times Cited: 11
The role of chromatin-related epigenetic modulations in CAKUT
Lars König, Miriam Schmidts
Current topics in developmental biology/Current Topics in Developmental Biology (2025)
Closed Access | Times Cited: 1
The FOXO family of transcription factors: key molecular players in gastric cancer
Ying Liu, Xiang Ao, Yi Jia, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 7, pp. 997-1015
Closed Access | Times Cited: 34
Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression
Jiayu Wang, Jiaxing Li, Xin Zhang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 25
HDAC6 inhibition: a significant potential regulator and therapeutic option to translate into clinical practice in renal transplantation
Qianqian Zhang, Weijie Zhang, Sheng Chang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
HDAC9-mediated deacetylation of CALML6 promotes excessive proliferation of glomerular mesangial cells in IgA nephropathy
Xingxing Zhuang, Fei Xiao, Feihu Chen, et al.
Clinical and Experimental Nephrology (2025)
Closed Access
Histone deacetylase inhibiting nanoprodrugs for enhanced chemodynamic therapy through multistage downregulating glutathione
Yongxin Liu, Xinlu Zhang, Xu Zhang, et al.
International Journal of Biological Macromolecules (2025) Vol. 305, pp. 141184-141184
Closed Access
Renal dysplasia development and chronic kidney disease
Li Zhang, Chunjiang Yang, Xing Liu, et al.
Pediatric Research (2025)
Closed Access
VPA improves ferroptosis in tubular epithelial cells after cisplatin-induced acute kidney injury
Yan Li, Ke Li, Weihao Zhao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Protein acetylation and related potential therapeutic strategies in kidney disease
Xiangyu Li, Ju-tao Yu, Yuhang Dong, et al.
Pharmacological Research (2023) Vol. 197, pp. 106950-106950
Open Access | Times Cited: 9
Editorial: Emerging talents in alloimmunity and transplantation: 2022
Guido Moll, Wai H. Lim, Olaf Penack
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Chronic kidney disease activates the HDAC6-inflammatory axis in the heart and contributes to myocardial remodeling in mice: inhibition of HDAC6 alleviates chronic kidney disease-induced myocardial remodeling
Sourav Kundu, Shobhit Gairola, Smriti Verma, et al.
Basic Research in Cardiology (2024) Vol. 119, Iss. 5, pp. 831-852
Closed Access | Times Cited: 2
Inhibition of HDAC6 with CAY10603 alleviates acute and chronic kidney injury by suppressing the ATF6 branch of UPR
Shuyan Kan, Qing Hou, Ruixiang Yang, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 756, pp. 110009-110009
Closed Access | Times Cited: 1
HDAC3 inhibition improves urinary‐concentrating defect in hypokalaemia by promoting AQP2 transcription
Long Xu, Haixia Xie, Shan Hu, et al.
Acta Physiologica (2022) Vol. 234, Iss. 4
Closed Access | Times Cited: 6
Class IIa histone deacetylase inhibition ameliorates acute kidney injury by suppressing renal tubular cell apoptosis and enhancing autophagy and proliferation
Jialu Li, Chao Yu, Fengchen Shen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Comprehensive Characterization of HATs and HDACs in Human Cancers Reveals Their Role in Immune Checkpoint Blockade
Rong Sun, Zike Chen, Xuanhao Qu, et al.
Critical Reviews in Eukaryotic Gene Expression (2023) Vol. 34, Iss. 1, pp. 41-53
Closed Access | Times Cited: 3
AIEgen based turn-on fluorescent probes of histone deacetylase 6 via restriction of molecular motion
Tao Li, Yu Zhang, Ziwei Wang, et al.
Sensors and Actuators B Chemical (2022) Vol. 364, pp. 131882-131882
Closed Access | Times Cited: 5
Renal insufficiency and chronic kidney disease – Promotor or consequence of pathological post-translational modifications
Jonas Laget, Flore Duranton, Àngel Argilés, et al.
Molecular Aspects of Medicine (2022) Vol. 86, pp. 101082-101082
Open Access | Times Cited: 4
Current Therapies in Nephrotic Syndrome: HDAC inhibitors, an Emerging Therapy for Kidney Diseases
Rini Varghese, Anuradha Majumdar
Current Research in Biotechnology (2021) Vol. 3, pp. 182-194
Open Access | Times Cited: 5
Immunolocalization patterns of histone-deacetylases in salivary glands of mice during postnatal development
Chubo Yang, Xuejing Song, Jiaqi Kong, et al.
Acta Histochemica (2024) Vol. 126, Iss. 2, pp. 152144-152144
Closed Access
Histone deacetylases 1 and 2 target gene regulatory networks of nephron progenitors to control nephrogenesis
Hongbing Liu, Nguyen Yen Nhi Ngo, Kyra F Herzberger, et al.
Biochemical Pharmacology (2022) Vol. 206, pp. 115341-115341
Closed Access
Page 1

Scroll to top